Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF FEBRUARY 13, 2016 FBO #5195
SOLICITATION NOTICE

Q -- Purchase of 100 Milligrams of Butyrylcholinesterase Antibody

Notice Date
2/11/2016
 
Notice Type
Presolicitation
 
NAICS
424210 — Drugs and Druggists' Sundries Merchant Wholesalers
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
2016-Q-64720
 
Archive Date
3/12/2016
 
Point of Contact
Timothy Williams, Phone: 7704882791
 
E-Mail Address
TLWilliams3@cdc.gov
(TLWilliams3@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
The Centers for Disease Control and Prevention (CDC), Office for Non-Communicable Diseases, Injury and Environmental Health (ONDIEH), National Center for Environmental Health (NCEH), Division of Laboratory Sciences (DLS) intends to award a sole source firm-fixed price purchase order to BioPorto Diagnostics A/S. The address is Tuborg Havnevej, ST 2900 HELLERUP Denmark. The statutory authority for this sole source acquisition is 10 U.S.C. 2304 (c) (1) in accordance with FAR Part 6.302-1- Only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS Code for this procurement is 424210. The Size Standard is 100 employees. The Government is seeking contractor support to purchase 100 Milligrams of Butyrylcholinesterase Antibody needed by the Emergency Response Branch (ERB). The purpose of this requirement is to restore the CDC's reagents on hand to maintain agency readiness. The ERB has developed several highly-specific and sensitive methods that require the highest quality reagents to meet CLIA specifications. Many of these methods rely on the specificity and reproducibility of the BioPorto Butyrylcholinesterase antibody. It is critical that subject matter experts on methodology development within the ERB have the ability to contact the antibody development experts at BioPorto directly to ensure proper steps were taken for quality control. Purchasing this specific product ensures the ERB's continuity of branch methodology and continual adherence to CLIA standards. No solicitation will be posted to FedBizOpps. We will only issue a solicitation to BioPorto Diagnostics A/S. BioPorto Diagnostics A/S is the only source available to provide this service that meets mission critical requirements. This notice of intent is not a request for proposal. A determination to compete this procurement based on response to this notice is solely within the discretion of the Contracting Officer. Interested parties who believe they possess the capability to satisfy this requirement should submit a capability statement demonstrating their ability to meet this requirement. All responses must be sent in writing to Mr. Tim Williams via email to TLWilliams3@cdc.gov using solicitation number 2016-Q-64720 in the subject line, no later than 12:00pm Eastern Time, February 26, 2016.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2016-Q-64720/listing.html)
 
Place of Performance
Address: Contractor Facility, Denmark
 
Record
SN04017528-W 20160213/160211234151-caf125c982d9b0a3907b389bd7fb099d (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.